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Abstract
Phyllodes tumours of the breast are characterized by having both an epithelial as well as
stromal component and these usually comprise almost 3% of all fibroepithelial tumours. They
are exceptional in this aspect to convert into a stromal sarcoma of the breast after multiple
recurrences. To the best of our knowledge, there are only three case reports regarding this in
the available literature as it is an exceptional change. In this case report, we present a case of
recurrent phyllodes transforming into a breast fibrosarcoma in a middle age postmenopausal
woman. Histopathological examination and immunohistochemistry of the lesion were
performed to confirm the diagnosis of breast fibrosarcoma.
Categories: Oncology
Keywords: phyllodes tumour, fibrosarcoma, breast
Introduction
Phyllodes tumours or biphasic tumours can be identified by its leaf-like architecture due to its
intra-canalicular growth pattern, cleft-like spaces lined by epithelium, and hyper cellular
stroma [1]. An approximate data statistics had revealed that it accounts for less than 1% of total
breast malignancies having attributed for about two cases per million women annually [1,2].
They are mostly encountered in women suffering from Li-Fraumeni syndrome [3]. Phyllodes
tumours of the breast have a propensity to transform into a breast sarcoma on recurrences
following surgery but at an unusually low incidence, therefore, there is a paucity of published
literature and knowledge; it is restricted to few retrospective case reviews and reports which
compelled us to present the following case of conversion. Phyllodes tumour with sarcomatous
differentiation run an extremely aggressive course, therefore, delay in its clinical diagnosis and
treatment approach leads to an unfavourable prognosis.
Case Presentation
This is a case of a 55-year-old postmenopausal woman who was initially subjected to
lumpectomy in 1994; the histopathology showed features of fibro adenoma. In 2011, she again
felt a lump at the scar site which was excised having histopathological features of benign
phyllodes tumour. Subsequently, from same site in 2014 and 2015, recurrences were excised
showing borderline phyllodes (8 x 4 x 3.5 cm) and malignant phyllodes (3.5 x 3 x 1 cm)
respectively, both with closest margin of 0.1 cm.
Partial mastectomy was performed in 2016; histopathological findings were consistent with
malignant phyllodes of 12 x 10 x 8.5 cm with closest painted margin of 0.2 cm. Following that,
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computed tomography (CT) scan of the chest, abdomen, and pelvis, as well as a bone scan, was
performed which were unremarkable. After three months of partial mastectomy, she underwent
total mastectomy showing evidence of low-grade fibrosarcoma (1.8 x 1.7 cm) with closest
margin of 1 cm (Figure 1).The previous pathological blocks were reviewed again by two senior
pathologists and findings were consistent with low-grade fibrosarcoma. Sections showed the
framework of the tumour was comprised of spindle cells exhibiting hyper and hypo cellular
areas. These were arrayed in loose interlacing fascicles. Individual neoplastic cells had
moderately pleomorphic, hyperchromatic nuclei, inconspicuous nucleoli and moderate
cytoplasm. At places, herring bone pattern was appreciated and stroma was myxoid (Figure 2).
Mitotic count was 20/10 high power field (HPF) and no necrosis nor epithelial component was
identified. The cells of the lesion were infiltrating skeletal muscle bundles.
FIGURE 1: Lumpectomy specimen showing a well-
circumscribed, rounded mass with areas of haemorrhage
(arrows)
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FIGURE 2: Spindle tumour cells arranged in a herring bone
pattern as indicated by arrows (haematoxylin & eosin stain)
Immunohistochemistry was carried out with the following immunohistochemical markers to
exclude malignant phyllodes tumour and metaplastic carcinoma: cluster of differentiation
(CD)34, S-100, cytokeratin (CK) AE1/3, and caldesmon (Figure 3). All were negative in spindle
cells supporting the diagnosis of breast fibrosarcoma. Later on, she was subjected to chest wall
radiation with boost total 7000 Gy. She remained quite well for 1.5 years; subsequently, she
developed three tiny nodules at the scar site, the largest was 1 cm (recurrences) which was
widely excised with latissimus dorsi flap coverage. In 2018, she developed bony metastasis and
pulmonary nodules with local recurrence under the flap. She was treated with metronomic
chemotherapy (adriamycin, cyclophosphamide); however, she succumbed to death after four
months of distant metastasis. 
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FIGURE 3: Immunohistochemical stains revealed tumour cells
negative for CD34 (A), S-100 (B), CKAE1/AE3 (C), and
caldesmon (D)
CD:cluster of differentiation; CKAE1/AE3: cytokeratin AE1/AE3.
Discussion
Phyllodes tumours formerly known as serocystic disease of Brodie or cystosarcoma phyllodes
have a predilection to be found in women who are above 40 years [2]. These fibroepithelial
tumours, firstly described by Chelius in 1827, constitute 2%-3% of all fibroepithelial tumours
[4]. On the basis of histological features, phyllodes tumours are stratified into three main
varieties as benign, borderline, and malignant. Fortunately, a significant proportion of
phyllodes tumours (60.0%-75.0%), encountered in clinical practice, are benign which are
generally cured by performing wide local excision and carries a lower local recurrence rate of
about 10.0%-20.0% [1].
The natural behaviour of phyllodes tumour is an interesting phenomenon; recurrence rates are
high like other stromal tumours, especially if subjected to incomplete excision, having positive
margins/or less aggressive surgical treatment. Recurrence may show higher histologic grade
with increase mitosis and higher potential for distant metastasis [5]. It is also worth mentioning
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that reported recurrence rates are high in malignant phyllodes if their size is less than or equal
to 4 cm; this was postulated because smaller tumours are subject to less aggressive surgical
treatment [6].
Earlier published studies have shown that 28%-44% of local recurrence in benign phyllodes
tumour present with higher histologic grades than the primary tumour, likewise borderline
phyllodes can show recurrence ranges from 14%-25% and transformation to malignant
phyllodes are seen in 12%-54% of recurrences [5,7].
Malignant phyllodes tumour have a completely different nature in comparison to the other two
types having aggressive behaviour and a much higher rate of local recurrence reported from
23%-30% [7]. Having said that, when malignant phyllodes recur, it would show a wide spectrum
of type of recurrences that could be benign in 0%-28% of cases; however, malignant recurrence
is the most common (71%-100%) [5]. An interesting fact among recurrences is that the atypical
changes within the stromal component can transform into sarcomatous features [8].
In this case, fibrosarcoma has been observed on recurrence of a recurrent phyllodes tumour
which is known to be the most common pattern of sarcomatous transformation, the second
being myxoliposarcoma. Others include chondrosarcoma, osteosarcoma, and leiomyosarcoma
[8]. Contrary to the other two reported cases, our patient developed an aggressive
transformation after multiple recurrences while in the case report by Gunasekaran et al., the
patient developed fibrosarcoma in the very first recurrence after surgery. In the other case
reported by Pant et al., the patient developed such change at the third recurrence [9,10].
Distant metastasis is rare in phyllodes tumour having a propensity for haematogenous spread
especially to the lungs, liver, and bones ranging from 9.0% - 27.0%. The treatment options are
limited; very few chemotherapeutic agents worked against these tumours with poor success
rate and worse outcome [1]. Literature review documented a median survival of four to
seventeen months with metastatic disease [11].
Treatment of phyllodes tumour is a challenging situation for multidisciplinary teams including
surgeons and medical and radiation oncologists. The rare nature of disease results in the
availability of only retrospective data including case reports and/or case series. Lack of
prospective data or trials pose a challenge among surgeons and oncologists to offer the best
possible treatment option to patients especially those who recurred, metastasized or both.
Conclusions
Transformation from phyllodes tumour to fibrosarcoma of the breast is a rare phenomenon
warranting accurate and timely diagnosis. These tumours are notorious for multiple
recurrences likewise other sarcomas. There is a paucity of data supporting the role of
radiotherapy and systemic chemotherapy in this rare disease to prevent recurrences and
systemic spread. In the case of metastatic disease, none of the cytotoxic or immunotherapeutic
agents has proven its efficacy.
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